Biotronik granted CE Mark approval for new ICD/CRT-D series

Biotronik has been granted European regulatory approval for a new range of implantable
cardioverter-defibrillator/cardiac resynchronisation therapy defibrillator (ICD/CRT-D) devices that offer numerous operational benefits.

The Ilesto 7 ICD/CRT-D range features ProMRI technology, which means that the devices are compatible with magnetic resonance imaging (MRI) scanning procedures, and also include one of the world's smallest ICDs.

Also providing superior longevity, the new products are currently being implanted among European patients for the first time after receiving CE Mark approval, adding a new option to a product range that also includes the MRI-compatible Lumax 740 ICD/CRT-D series.

Christoph Bohmer, international president at Biotronik, said: "Our Ilesto implants and Linox Smart leads are designed to continue our tradition of providing products with the highest reliability."

Earlier this month, the company reported positive data from a new study of its Home Monitoring technology, which demonstrated the product's benefits in improving care quality for patients with cardiac devices.